1. |
Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J]. JAMA, 2017, 317(24): 2515-2523. DOI: 10.1001/jama.2017.7596.
|
2. |
Zhang G, Chen H, Chen W, et al. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study[J]. Br J Ophthalmol, 2017, 101(12): 1591-1595. DOI: 10.1136/bjophthalmol-2017-310316.
|
3. |
Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified airlie house classification. ETDRS report number 10[J]. Ophthalmology, 1991, 98(5 Suppl): S786-806.
|
4. |
Nagiel A, Lalane RA, Sadda SR, et al. Ulrea-widefield fundus imaging: a review of clinical applications and future trends[J]. Retina, 2016, 36(4): 660-678. DOI: 10.1097/iae.0000000000000937.
|
5. |
Cicinelli MV, Cavalleri M, Brambati M, et al. New imaging systems in diabetic retinopathy[J]. Acta Diabetol, 2019, 56(9): 981-994. DOI: 10.1007/s00592-019-01373-y.
|
6. |
Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, et al. Glomerular filtration rate and/or ratio of urine albumin to creatinine as markers for diabetic retinopathy: a ten-year follow-up study[J/OL]. J Diabetes Res, 2018, 2018: 5637130[2018-02-26]. https://pubmed.ncbi.nlm.nih.gov/29682579/. DOI: 10.1155/2018/5637130.
|
7. |
Verma A, Alagorie AR, Ramasamy K, et al. Distribution of peripheral lesions identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy[J]. Graefe's Arch Clin Exp Ophthalmol, 2020, 258(4): 725-733. DOI: 10.1007/s00417-020-04607-w.
|
8. |
Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J]. Ophthalmology, 2003, 110(9): 1677-1682. DOI: 10.1016/s0161-6420(03)00475-5.
|
9. |
Sears CM, Nittala MG, Jayadev C, et al. Comparison of subjective assessment and precise quantitative assessment of lesion distribution in diabetic retinopathy[J]. JAMA Ophthalmol, 2018, 136(4): 365-371. DOI: 10.1001/jamaophthalmol.2018.0070.
|
10. |
Aiello LP, Odia I, Glassman AR, et al. Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy[J]. JAMA Ophthalmol, 2019, 137(1): 65-73. DOI: 10.1001/jamaophthalmol.2018.4982.
|
11. |
Silva PS, Cavallerano JD, Haddad NM, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years[J]. Ophthalmology, 2015, 122(5): 949-956. DOI: 10.1016/j.ophtha.2015.01.008.
|
12. |
Hafner J, Pollreisz A, Egner B, et al. Presence of peripheral lesions and correlation to macular perfusion, oxygenation and macular neurodegeneration in early tye Ⅱ diabetic retinal desease[J]. Retina, 2020, 40(10): 1964-1971. DOI: 10.1097/iae.0000000000002704.
|
13. |
Silva PS, Horton MB, Clary D, et al. Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program[J]. Ophthalmology, 2016, 123(6): 1360-1367. DOI: 10.1016/j.ophtha.2016.01.043.
|
14. |
Silva PS, El-Rami H, Barham R, et al. Hemorrhage and/or microaneurysm severity and count in ultrawide field images and early treatment diabetic retinopathy study photography[J]. Ophthalmology, 2017, 124(7): 970-976. DOI: 10.1016/j.ophtha.2017.02.012.
|
15. |
Silva PS, Cavallerano JD, Sun JK, et al. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity[J]. Ophthalmology, 2013, 120(12): 2587-2595. DOI: 10.1016/j.ophtha.2013.05.004.
|
16. |
Hafner J, Ginner L, Karst S, et al. Regional patterns of retinal oxygen saturation and microvascular hemodynamic parameters preceding retinopathy in patients with type Ⅱ diabetes[J]. Invest Ophthalmol Vis Sci, 2017, 58(12): 5541-5547. DOI: 10.1167/iovs.17-22523.
|